0001493152-26-013513
SEC filingQHSLab, Inc. (USAQ) delivered mixed FY2025 results, with robust top-line and gross profit growth offset by lower operating income and a full-year swing to net profitability.
FY2025 revenue increased 26.3% year-over-year to $2.7M, while gross profit grew 33.4% to $1.8M, delivering a 67.3% gross margin for the period. The year-over-year improvement in gross margin is attributable to a combination of favorable product mix shifts, including growth in ISP revenue, and an improved cost structure resulting from the acquisition of intangible assets from MedScience and synergies across the company’s core product lines. As the company continues to introduce new products early in its development cycle, management notes gross margins may vary significantly between periods due to differences in customer and product mix, customer negotiating strength, and other operational factors.
Operating income fell 36.2% year-over-year to $131.2K for FY2025, driven by intentional increases in operational spending to support long-term growth objectives. General and administrative expenses rose due to higher sales processing costs tied to increased revenue, higher rent, investor relations costs, and legal fees associated with 2025 debt settlement activities. R&D spending increased to fund ongoing platform expansion, while sales and marketing expenses rose to support customer acquisition efforts. Management expects both R&D and sales & marketing spending will continue to rise as the company launches new products and expands its customer base of independent, physician-led primary care practices, the core target of its sales strategy.
The company delivered a net income of $457.4K for FY2025, a marked improvement from the $259.2K net loss recorded in FY2024, with diluted earnings per share coming in at $0.02 compared to a $0.03 per share loss in the prior year. Net cash provided by operating activities totaled $178.1K for FY2025, up from $142.4K generated in FY2024. QHSLab operates as a single reportable operating segment. Management expects working capital requirements will increase in line with business growth, but notes existing working capital and anticipated cash flows are expected to be adequate to fund operations over the next twelve months.